−2.36USD
−74.733MUSD
19.635M
About NextCure, Inc.
Sector
CEO
Michael S. Richman
Headquarters
Beltsville
Website
Employees (FY)
99
Founded
2015
ISIN
US65343E1082
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.
Closing the Gap: NXTC breakoutHi mates there is my another swingtrade.After huge selloff this year, NXTC is in pretty strong uptrend on daily now. There is gap topping 17.55. I expect momentum breakout in few days.
here is data for my trade:
------------------------Trade setup ---------------------------
Entry: 13.60
Stop Loss:
$NXTC NextCure Inc increasingly Bullish Setup Developing
Alert set for break above local downtrend resistance.
Gap fill resistance and Pivot Point is first major target @ $12.97
Volume is bullish and Fridays candle is very encouraging.
RSI MACD & histogram in bullish Trajectory.
Strong bounce off the 50ma.
Alternative is to set alert on the gap fill f
$NXTC NextCure Inc On Breakout Watchlist
Speculative BIO stock with the potential for a breakout in the coming days.
Alerts et for break above downtrend.
Stochastic bottomed and reversing bullishly.
Moving averages reclaimed as support.
RSi just moved above mid-point.
MACD reversal, crossover imminent.
Needs a spike in volume.
NXTC BullishThe chart looks bullish after consolidating since mid July. The MACD crossed a few days ago and the stock broke out of the descending trend lines. First target 12.81
Large CME gap buy option calls for $17An overwhelming percent of the time stocks fill gaps, facts of life.. This one’s got a big gap as noticeable as if bugs bunny would be missing his two front teeth..
Consolidation doesn’t usually last for very long the stock is very much oversold as shown clearly in the chart you can choose to eith
Severely oversold $NXTC #LongWay over sold imo - interesting setup.
This is incredibly oversold easy target of $20. Get long just a beautiful setup.
The sales Q/Q are +1,549.10% (Bullish)
EPS Q/Q +218.20% (Bullish)
Profit Margin is -65% (Very Bearish)
Debt/Eq 0.01 (Bullish)
Current Ratio 40.10 (this is good)
P/B (0.77) (Bulli
Extremely oversold - great long opportunity $NXTC #NextCureNextCure is an easy long right now as it is extremely oversold. Price target would be so in the money, could ride out a chunk of the position. Recommend adding to watchlist.
Updated EW count for NXTCpretty weak bounce off 38.2 retracement that I was expecting. Most likely this is a correction of a correction. Should get a deeper retracement to 68 percene.t
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
